Time to Completion of Breast Cancer Treatment and Survival
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
https://link.springer.com/content/pdf/10.1245/s10434-021-10116-9.pdf
Reference16 articles.
1. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013;148(6):516–23. https://doi.org/10.1001/jamasurg.2013.1680.
2. Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330. https://doi.org/10.1001/jamaoncol.2015.4508.
3. Khorana AA, Tullio K, Elson P, et al. Time to initial cancer treatment in the United States and association with survival over time: an observational study. PLoS One. 2019;14(3):e0213209. https://doi.org/10.1371/journal.pone.0213209.
4. Downing A, Twelves C, Forman D, Lawrence G, Gilthorpe MS. Time to begin adjuvant chemotherapy and survival in breast cancer patients: a retrospective observational study using latent class analysis. Breast J. 2014;20(1):29–36. https://doi.org/10.1111/tbj.12209.
5. Williams BA, Mandrekar JN, Mandrekar SJ, Cha SS, Furth AF. Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes. Tech Rep Ser. 2006;79:1–26.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Structural Racism and Treatment Delay Among Black and White Patients With Breast Cancer;Journal of Clinical Oncology;2024-08-06
2. Patient-reported observations on medical procedure timeliness (PROMPT) in breast cancer: a qualitative study;Breast Cancer Research and Treatment;2024-07-04
3. Factors delaying non‐metastatic breast cancer adjuvant therapy and impact on prognosis in a cohort of Brazilian women;Journal of Evaluation in Clinical Practice;2024-06-06
4. Ethnoracial Disparities in Breast Cancer Treatment Time and Survival: A Systematic Review With a DAG-based Causal Model;2024-06-03
5. Favorable outcome of neoadjuvant endocrine treatment than surgery‐first in female HR‐positive/HER2‐negative breast cancer patients—A NCDB analysis (2010–2016);Cancer Medicine;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3